Technical aspects of quality assurance for intravitreal injections (IVI)

被引:0
|
作者
Bucher, F. [1 ]
Mussinghoff, P. [2 ]
Kuehn, T. [3 ]
Stahl, A. [4 ]
Boehringer, D. [1 ]
机构
[1] Univ Klinikum Freiburg, Klin Augenheilkunde, Killianstr 5, D-79106 Freiburg, Germany
[2] St Franziskus Hosp Munster, Augenzentrum, Munster, Germany
[3] ContraCare GmbH, Nurnberg, Germany
[4] Univ Med Greifswald, Klin & Poliklin Augenheilkunde, Greifswald, Germany
来源
OPHTHALMOLOGE | 2020年 / 117卷 / 04期
关键词
Network architecture; Treatment data; Data protection; Standardized data formats; Data availability;
D O I
10.1007/s00347-019-01029-w
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Successful quality assurance in intravitreal injection (IVI) of medications requires a complex information technology infrastructure. The main challenges are data availability independent of location, standardization of clinical data, integration of extensive and currently non-standardized image documentation from coherence tomography and compliance with data protection regulations. Objective In this article the technical implementation and data protection principles are reviewed. Material and methods Essential aspects in the implementation of quality assurance in the field of IVI are discussed in a systematic approach. Results In the field of network architectures web-based applications supplemented by local virtual private networks (VPN) and/or other software instances have recently replaced the previously commonly used physical data medium exchange. The standardization of the data, e.g. by converting the visual acuity into logMAR, plays an important role in the collection of treatment data. Multiple non-standardized data formats in optical coherence tomography complicate the general quality assurance structure and comparability of data. Conclusion International standards will probably facilitate this in the near future. Until then individual solutions have to be found on site.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 50 条
  • [11] Topical bromfenac 0.09% solution reduces pain following intravitreal vascular endothelial growth factor injections (IVI)
    Achuck, Kathryn
    Soares, Rebecca
    Garg, Sunir
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [12] GENERAL ASPECTS OF QUALITY ASSURANCE
    PAARDEKOOPER, EJC
    ANTONIE VAN LEEUWENHOEK JOURNAL OF MICROBIOLOGY, 1975, 41 (03): : 368 - 368
  • [13] Current aspects of quality assurance
    Hartung, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (04): : 367 - 371
  • [14] THE ROYAL-MARSDEN-HOSPITAL PELVIC RADIOTHERAPY TRIAL - TECHNICAL ASPECTS AND QUALITY ASSURANCE
    MAYLES, WPM
    CHOW, M
    DYER, J
    FERNANDEZ, EM
    HEISIG, S
    KNIGHT, RT
    MOORE, I
    NAHUM, AE
    SHENTALL, GS
    TAIT, DM
    RADIOTHERAPY AND ONCOLOGY, 1993, 29 (02) : 184 - 191
  • [15] QUALITY ASSURANCE AND LANGUAGES IN TECHNICAL EDUCATION
    Greculescu, Anca
    Solomon, Gheorghe
    ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL, 2009, 8 (04): : 715 - 719
  • [16] Technical Assurance for Construction Quality Management
    Jiang, Haohao
    FRONTIERS OF GREEN BUILDING, MATERIALS AND CIVIL ENGINEERING, PTS 1-8, 2011, 71-78 : 3397 - 3400
  • [18] HUMAN ASPECTS OF QUALITY ASSURANCE.
    MASING, W.E.
    1982, V 8 (N 2): : 35 - 38
  • [19] Quality assurance aspects of vitamin analysis
    Greaves, R. F.
    Jolly, L. M.
    Woollard, G. A.
    Hoad, K. E.
    Walmsley, T. A.
    Briscoe, S.
    Johnson, L. A.
    Salonikas, C.
    Gill, J. P.
    CLINICA CHIMICA ACTA, 2010, 411 (11-12) : 903 - 904
  • [20] Aspects of quality assurance in gynecological endoscopy
    Gruber, I. V.
    Schmidt, E. H.
    Frank, V.
    De Wilde, R. L.
    Wallwiener, D.
    Brucker, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (04) : 352 - 358